Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:GBT - FR0000032526 - Common Stock

18.04 EUR
+0.1 (+0.56%)
Last: 11/27/2025, 5:21:07 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to GBT. GBT was compared to 63 industry peers in the Health Care Equipment & Supplies industry. GBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GBT has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year GBT was profitable.
GBT had a positive operating cash flow in the past year.
Of the past 5 years GBT 4 years were profitable.
Each year in the past 5 years GBT had a positive operating cash flow.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.76%, GBT is doing worse than 60.32% of the companies in the same industry.
GBT has a Return On Equity of 2.06%. This is in the lower half of the industry: GBT underperforms 60.32% of its industry peers.
GBT's Return On Invested Capital of 3.17% is on the low side compared to the rest of the industry. GBT is outperformed by 63.49% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GBT is significantly below the industry average of 9.33%.
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROIC 3.17%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

The Profit Margin of GBT (0.96%) is worse than 60.32% of its industry peers.
GBT's Profit Margin has declined in the last couple of years.
The Operating Margin of GBT (4.23%) is worse than 63.49% of its industry peers.
In the last couple of years the Operating Margin of GBT has declined.
GBT has a better Gross Margin (78.03%) than 90.48% of its industry peers.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

GBT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GBT has about the same amount of shares outstanding.
GBT has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, GBT has a worse debt to assets ratio.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

GBT has an Altman-Z score of 2.10. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.10) which is in line with its industry peers.
GBT has a debt to FCF ratio of 8.88. This is a slightly negative value and a sign of low solvency as GBT would need 8.88 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.88, GBT is in line with its industry, outperforming 47.62% of the companies in the same industry.
A Debt/Equity ratio of 0.93 indicates that GBT is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.93, GBT is doing worse than 79.37% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Altman-Z 2.1
ROIC/WACC0.46
WACC6.95%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.32, GBT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
A Quick Ratio of 1.03 indicates that GBT should not have too much problems paying its short term obligations.
The Quick ratio of GBT (1.03) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.03
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for GBT have decreased strongly by -76.89% in the last year.
Measured over the past years, GBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.50% on average per year.
GBT shows a decrease in Revenue. In the last year, the revenue decreased by -2.01%.
GBT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.59% yearly.
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%

3.2 Future

GBT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.56% yearly.
Based on estimates for the next years, GBT will show a small growth in Revenue. The Revenue will grow by 3.86% on average per year.
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-3.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y1.12%
Revenue Next 5Y3.86%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.57 indicates a quite expensive valuation of GBT.
Based on the Price/Earnings ratio, GBT is valued a bit cheaper than the industry average as 61.90% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 26.15. GBT is around the same levels.
The Price/Forward Earnings ratio is 12.35, which indicates a correct valuation of GBT.
Based on the Price/Forward Earnings ratio, GBT is valued cheaply inside the industry as 84.13% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.12, GBT is valued rather cheaply.
Industry RankSector Rank
PE 29.57
Fwd PE 12.35
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 93.65% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, GBT is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 5.08
EV/EBITDA 4.35
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as GBT's earnings are expected to decrease with -10.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%

3

5. Dividend

5.1 Amount

GBT has a Yearly Dividend Yield of 2.69%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.22, GBT pays a better dividend. On top of this GBT pays more dividend than 85.71% of the companies listed in the same industry.
GBT's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.69%

5.2 History

The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

GBT pays out 81.48% of its income as dividend. This is not a sustainable payout ratio.
The Dividend Rate of GBT has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP81.48%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (11/27/2025, 5:21:07 PM)

18.04

+0.1 (+0.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-23 2025-10-23
Earnings (Next)02-04 2026-02-04
Inst Owners15.78%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap228.03M
Revenue(TTM)809.67M
Net Income(TTM)7.74M
Analysts46
Price Target16.58 (-8.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.69%
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.48%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.96%
PT rev (3m)-38.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-60.62%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-6.14%
Valuation
Industry RankSector Rank
PE 29.57
Fwd PE 12.35
P/S 0.28
P/FCF 5.08
P/OCF 2.44
P/B 0.61
P/tB 0.83
EV/EBITDA 4.35
EPS(TTM)0.61
EY3.38%
EPS(NY)1.46
Fwd EY8.1%
FCF(TTM)3.55
FCFY19.68%
OCF(TTM)7.41
OCFY41.05%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.21
Profitability
Industry RankSector Rank
ROA 0.76%
ROE 2.06%
ROCE 4.49%
ROIC 3.17%
ROICexc 3.67%
ROICexgc 4.33%
OM 4.23%
PM (TTM) 0.96%
GM 78.03%
FCFM 5.54%
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 8.88
Debt/EBITDA 3.26
Cap/Depr 66.32%
Cap/Sales 6.02%
Interest Coverage 1.61
Cash Conversion 86.9%
Profit Quality 580.05%
Current Ratio 2.32
Quick Ratio 1.03
Altman-Z 2.1
F-Score5
WACC6.95%
ROIC/WACC0.46
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-3.81%
Revenue Next 2Y-0.32%
Revenue Next 3Y1.12%
Revenue Next 5Y3.86%
EBIT growth 1Y-41.57%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year61.5%
EBIT Next 3Y25.44%
EBIT Next 5Y21.78%
FCF growth 1Y183.49%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2774.75%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%

GUERBET / GBT.PA FAQ

What is the ChartMill fundamental rating of GUERBET (GBT.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.


Can you provide the valuation status for GUERBET?

ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.


How profitable is GUERBET (GBT.PA) stock?

GUERBET (GBT.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for GBT stock?

The financial health rating of GUERBET (GBT.PA) is 4 / 10.


How sustainable is the dividend of GUERBET (GBT.PA) stock?

The dividend rating of GUERBET (GBT.PA) is 3 / 10 and the dividend payout ratio is 81.48%.